High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: A systematic review of randomised clinical trials

Annals of Oncology

Volumn 12, Issue 3, 2001, Pages 289-300

  Maltoni, M ^a   Nanni, O ^b   Scarpi, E ^b   Rossi, D ^b   Serra, P ^b   Amadori, D ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

Author keywords

Advanced cancer; Anorexia; Cachexia; Medroxy progesterone acetate; Megestrol acetate; Randomised clinical trials

Indexed keywords

MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PLACEBO; PROGESTERONE DERIVATIVE;

ADULT; AGED; ANOREXIA; APPETITE; BODY WEIGHT; CACHEXIA; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUSHING SYNDROME; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; DYSPNEA; EDEMA; HEARTBURN; HUMAN; HYPERTENSION; LUNG EMBOLISM; MORBIDITY; MUSCLE CRAMP; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SHORT COURSE THERAPY; THROMBOEMBOLISM; THROMBOPHLEBITIS; THROMBOSIS; TREATMENT OUTCOME; TREMOR; VOMITING; WEIGHT GAIN;

ANOREXIA; APPETITE; BODY WEIGHT; CACHEXIA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; NEOPLASMS; PROGESTINS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SYNDROME;

EID: 0035067434     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011156811739     Document Type: Review

References (50)

1. Clinical epidemiology of cancer cachexia
2. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group
3. Nutrition in cancer patients: An update and review of our experience
4. The cancer anorexia-cachexia syndrome
5. The pathophysiology of cancer cachexia
6. Cachectin/tumour necrosis factor production by cancer patients
7. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: Interactions and therapeutic options
8. Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients
9. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?
10. IV hyperalimentation and chemotherapy for stage III testicular cancer: A randomized study
11. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study
12. Clinical symptoms and length of survival in patients with terminal cancer
13. Parenteral nutrition: Is it oncologically logical?
14. Guidelines on artificial nutrition versus hydration in terminal cancer patients
15. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia-cachexia
16. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study
17. A phase II study of delta-nine-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia
18. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia
19. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer
20. Influence of nadrolone decanoate on weight-loss in advanced non-small-cell lung cancer
21. Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot study
22. Thalidomide in patients with cachexia due to terminal cancer: Preliminary report
23. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome
24. High-dose megestrol acetate. A possible treatment for cancer-cachexia
25. Randomized trial of low-versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer
26. Cytokine involvement in cancer anorexia-cachexia: Role of megestrol acetate and medroxyprogesterone acetate on cytokine down regulation and improvement of clinical symptoms
27. Body-composition changes in patients who gain weight while receiving megestrole-acetate
28. Systematic literature review and meta-analysis
29. Meta-analysis in clinical trials
30. Meta-analysis in clinical research
31. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer
32. Effectiveness of megestrol acetate in patients with advanced cancer: A randomised, double-blind, crossover study
33. Megestrol acetate for anorexia in patients with far-advanced cancer: A double-blind controlled clinical trial
34. Usefulness of megestrol acetate in cancer cachexia and anorexia
35. Risks and benefits of various therapies for cancer anorexia
36. Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: A placebo-controlled multicentric study
37. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia
38. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial. Australasian megestrol acetate cooperative study group
39. A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia
40. Placebo-controlled trial of medroxyprogesterone acetate in gastrointestinal malignancies and cachexia
41. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia
42. Effect of medroxyprogesterone acetate on the quality of life of the oncologic patient: A multicentric cooperative study
43. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A north central cancer treatment group study
44. Megestrol acetate in cancer anorexia and weight loss
45. Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: A placebo-controlled, randomised, multicentre trial
46. Methodologic issues in effectiveness research on palliative cancer care: A systematic review
47. Research into symptoms other than pain
48. Placebo-controlled trials in palliative care: The argument against
49. Meta-analysis
50. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia